MENDLEIN JOHN - Insider Non-Derivative Transactions at FATE THERAPEUTICS INC (FATE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 19, 2023, MENDLEIN JOHN's relationship to FATE THERAPEUTICS INC (FATE) is Director, and currently has 311,231 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FATE insiders.
Data Source: SEC.
MENDLEIN JOHN - Insider Non-Derivative Transactions of FATE Common Stock
MENDLEIN JOHN - Insider Non-Derivative Transactions at FATE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 20, 2023 | M -- (Common Stock) | 28461 | 1.37 | 311231 |
| Jan 14, 2023 | P -- (Common Stock) | 36631 | 5.43 | 282770 |
| Jan 12, 2023 | P -- (Common Stock) | 88048 | 5.67 | 246139 |